Literature DB >> 21951624

Liver involvement during influenza infection: perspective on the 2009 influenza pandemic.

Neven Papic1, Ana Pangercic, Martina Vargovic, Bruno Barsic, Adriana Vince, Ilija Kuzman.   

Abstract

Elevation of liver transaminase levels is a frequent observation during systemic infections. The aim of our study was to investigate liver damage during pandemic 2009 influenza A/H1N1 infection in comparison with seasonal influenza. Serum levels of aspartate aminotransferase, alanine aminotransferase, and gamma-glutamyl transpeptidase (GGT) were significantly higher in patients with pandemic influenza compared to seasonal influenza, which was strongly correlated with hypoxia. Moreover, a positive correlation between C-reactive protein and serum GGT, alkaline phosphatase, and lactate dehydrogenase was noticed. Our findings support the hypothesis that the pandemic 2009 influenza A/H1N1 is an illness with a significant immune response to infection leading to hepatocellular injury.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21951624      PMCID: PMC4941665          DOI: 10.1111/j.1750-2659.2011.00287.x

Source DB:  PubMed          Journal:  Influenza Other Respir Viruses        ISSN: 1750-2640            Impact factor:   4.380


Introduction

On June 11, 2009, the outbreak of a new strain of influenza A virus subtype H1N1 was officially declared by the World Health Organization to be the first influenza pandemic of the 21st century. Reports of pandemic 2009 influenza A/H1N1 described a virus that is more pathogenic than seasonal influenza and that caused severe infection and complications in relatively young, otherwise healthy individuals. , The occurrence of liver involvement during influenza infection is intriguing owing to the virus characteristic of only infecting the epithelial cells of the respiratory tract. Although the liver may not be the primary target organ of viral infection, it can be collaterally damaged. , Hepatic changes may be a consequence of the immune response to viral antigens with a close topographic association between the presence of viral antigens and the associated inflammatory infiltrates in liver. , In the novel pandemic 2009 influenza A/H1N1, it is still unclear how significant the liver damage is. The aim of our study was to compare liver injury during influenza A/H1N1 (2009) infection with seasonal influenza.

Patients and methods

A retrospective study that included cases of pandemic influenza during the outbreak of pandemic 2009 influenza A/H1N1 from June 1, 2009, until April 1, 2010, and seasonal influenza during 2008 and 2009 seasonal epidemics, was conducted at the University Hospital for Infectious Diseases Zagreb. Patient records were extracted and used for collection of clinical and laboratory data. Only cases with positive RT‐PCR and/or direct immunoflorescence of sputum or nasal swab were included in study. Of the 294 cases reviewed, we excluded a total of 110 patients: 72 who were under 15 years of age, 11 with underlying liver or bile duct diseases, eight with medical conditions that could influence liver function tests (e.g., chemotherapy and hepatotoxic drugs), and 19 patients with positive blood cultures. The patients were classified into two groups: pandemic and seasonal. We analyzed the clinical data and the results of routine biochemical and liver function tests performed on the first day of hospitalization before commencing antiviral therapy (oseltamivir). Statistical analysis was performed using Prism (version 5.0) statistical software (GraphPad Software, San Diego, CA, USA). The demographic, clinical, and laboratory data were evaluated and presented descriptively. Fisher’s exact test and Mann–Whitney U test were used to compare the two groups, as appropriate. Pearson’s correlation coefficient was applied to measure the degree of association between the parametric variables, and Spearman’s rho for nonparametric variables. P < 0·05 values were considered significant.

Results

Patients’ characteristic

The pandemic group consisted of 97 patients: 54 (56·25%) men and 43 (43·75%) women, mean age 46·79 ± 15·69 years. The seasonal group included 86 patients: 52 (60·45%) men and 34 (39·55%) women, mean age 47·06 ± 22·55 years. In the seasonal group, all patients had influenza A, but only some of the strains were subtyped (of those 68·60% had A/H1N1 and 31·40% H3N2 subtype). There was no significant difference in sex and age between the two groups (P = 0·5504 and P = 0·9377, respectively). In the pandemic group, levels of liver enzymes were more often above normal range than in the seasonal group: aspartate aminotransferase (AST) (35·78% versus 18·60%, P = 0·01245), alanine aminotransferase (ALT) (26·31% versus 7·36%, P = 0·0016), gamma‐glutamyl transpeptidase (GGT) (36·84% versus 16·47%, P = 0·0025), and lactate dehydrogenase (LDH) (50·00% versus 33·33%, P = 0·0387, Fisher’s exact test). Most of the patients had mild hepatic lesions, representing a pattern of hepatocellular injury. In patients with liver enzyme abnormalities, the transaminase level was elevated 2·5‐fold and normalized rapidly over several days (Table 1).
Table 1

 Hematological and biochemical parameters

Laboratory referencePandemic 2009 A influenza (H1N1) 
Mean (IQR)Seasonal influenza 
(2007–2009) 
Mean (IQR) P‐value*
C‐reactive protein (mg/l)<576·18 (22·20–98·95)56 (12·53–81·58) 0·0122
Leukocytes (×109/l)3·4–9·78·1 (5·275–9·825)8·24 (5·3–10·03)0·5911
Thrombocytes (×109/l)158–424184·09 (143–217)197 (148·5–227·0)0·0884
Fibrinogen (g/l)1·8–3·56·00 (4·79–7·11)5·31 (3·25–6·08)0·0876
d‐dimer (mg/l)<0·350·58 (0·185–0·365)0·38 (0·155–1·203)0·7436
Total bilirubin (μmol/l)3–2018·04 (6·9–16·70)12·54 (6·30–14·75)0·1780
AST (U/l)8–3848·66 (20–59)31·91 (20·75–35·25) 0·0172
ALT (U/l)10–4845·89 (18–47)27·33 (16–31) 0·0017
GGT (U/l)Men: 11–55 
Women: 9–3571·79 (19–67)34·52 (15·50–38) 0·0055
ALP (U/l)Men: 60–142 
Women: 50–15384·23 (55–90·25)77·08 (52–85·75)0·4314
LDH (U/l)<241316·82 (202–360)250·22 (177·5–265·5) 0·0096

IQR, interquartile range; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, gamma‐glutamyl transpeptidase; ALP, alkaline phosphatase; LDH, lactate dehydrogenase.

*Mann–Whitney U test. P < 0.05 values are significant

Hematological and biochemical parameters IQR, interquartile range; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, gamma‐glutamyl transpeptidase; ALP, alkaline phosphatase; LDH, lactate dehydrogenase. *Mann–Whitney U test. P < 0.05 values are significant

Relationship between peripheral oxygen saturation (SpO2), CRP, and liver injury

Hypoxemia (oxygen saturation <95%), measured by pulse oxymeter at the time of patient admission to hospital, was observed in 47·25% (43/91) of pandemic, but only in 18·6% (16/70) of the seasonal group (P < 0·0001, Fisher’s exact test). Peripheral oxygen saturation range was 84–100%. Sixteen patients had oxygen saturation ≤90% (17·58%) in the pandemic and 6 (8·57%) in the seasonal group. To identify the relationship between liver enzymes levels, C‐reactive protein (CRP), and LDH with SpO2, correlation–regression analysis was performed (Figure 1A, B).
Figure 1

 (A, B) Correlation between liver enzymes and peripheral oxygen saturation in pandemic 2009 influenza A/H1N1 and seasonal influenza, respectively. (C, D) Correlation between C‐reactive protein and liver enzymes in pandemic 2009 influenza A (H1N1) and seasonal influenza, respectively. Pearson’s r value and P‐value were presented. P < 0·05 is considered significant. AST, Aspartate aminotransferase; ALT, alanine aminotransferase; GGT, gamma‐glutamyl transpeptidase; ALP, alkaline phosphatase; LDH, lactate dehydrogenase; BIL, total bilirubin; CRP, C‐reactive protein; SpO2, pulse oximeter oxygen saturation.

(A, B) Correlation between liver enzymes and peripheral oxygen saturation in pandemic 2009 influenza A/H1N1 and seasonal influenza, respectively. (C, D) Correlation between C‐reactive protein and liver enzymes in pandemic 2009 influenza A (H1N1) and seasonal influenza, respectively. Pearson’s r value and P‐value were presented. P < 0·05 is considered significant. AST, Aspartate aminotransferase; ALT, alanine aminotransferase; GGT, gamma‐glutamyl transpeptidase; ALP, alkaline phosphatase; LDH, lactate dehydrogenase; BIL, total bilirubin; CRP, C‐reactive protein; SpO2, pulse oximeter oxygen saturation. It revealed that AST, ALT, GGT, and LDH were negatively correlated with SpO2 in the pandemic group. Similarly, a negative correlation was observed in the seasonal group between AST, alkaline phosphatase (ALP), and bilirubin with SpO2. Our study demonstrates a positive correlation between CRP and serum GGT, ALP, and LDH in seasonal and serum bilirubin and ALP in the pandemic group, as presented in Figure 1C, D.

Correlation between duration of hospitalization and liver involvement

In the pandemic group, duration of hospitalization was strongly correlated with age (r = 0·4292, P < 0·0001), CRP (r = 0·2840, P = 0·0064), bilirubin (r = 0·2421, P = 0·0208), GGT (r = 0·3133, P = 0·0025), ALP (r = 0·3924, P = 0·0009), and LDH (r = 0·2825, P = 0·0067) levels. In the seasonal group, duration of hospitalization was strongly correlated with age (r = 0·3220, P = 0·0025), CRP (r = 0·3235, P = 0·0024), bilirubin (r = 0·2767, P = 0·0108), and AST (r = 0·3730, P = 0·0004), ALT (r = 0·2604, P = 0·0154), GGT (r = 0·2745, P = 0·0110), and ALP (r = 0·2617, P = 0·0190) levels.

Discussion

Liver damage does not typically occur in seasonal influenza. To the best of our knowledge, this is the first report comparing liver involvement in seasonal influenza A (H1N1 and H3N2) and pandemic 2009 influenza A/H1N1. Elevation of liver transaminase levels is a frequent observation during systemic infections. , , However, the incidence of liver injury in influenza has not been established and the pathogenesis of liver involvement is still not well understood. Liver damage has been shown in animal models, revealing that virus replication is not needed to produce hepatocellular injury. Production of cytokines (e.g., TNF‐alpha, IL‐6, IL‐8, IL‐10, and interferon alpha, interferon beta, and interferon gamma) is responsible for the hepatic oxidative stress leading to the hepatocyte injury. , Polakos et al. introduced a so called collateral damage model and revealed that liver lesions occur because of the systemic immune response (SIRS) where, in the absence of viral antigens, the hepatocytes are damaged by viral‐specific CD8+ T cells. Our study offers some interesting findings of liver involvement during influenza infection. First, liver damage was more intensive with pandemic 2009 A/H1N1 than during recent seasonal influenza A. According to our study, serum levels of AST, ALT, and GGT were significantly higher in the pandemic group. Second, abnormalities in serum liver enzymes are strongly correlated with hypoxemia. Because hypoxemia (especially when severe) was more frequent in the pandemic group, the greater liver damage is presumably related to hypoxemia. However, no characteristic findings of ischemic hepatitis were found in any of our patients. All of the patients had mild, transient hepatic lesions. Third, a positive correlation between CRP and serum liver enzymes was noted. Previous studies have found associations between GGT and ALP with CRP or other inflammatory parameters (e.g., leukocytes and fibrinogen). , , CRP is a nonspecific biomarker of acute inflammation and is produced primarily in the liver. Our study revealed significantly higher levels of CRP in the pandemic group. Considering new increasing evidence , , showing that liver enzymes are associated with oxidative stress and inflammation, we can presume that pandemic influenza promotes a more intense SIRS than seasonal influenza. SIRS finally produces perfusion disturbances of the tissue which contributes to hepatocellular damage and hypertransaminemia. , Bermejo‐Martin et al. observed higher levels of pro‐inflammatory cytokines in pandemic 2009 influenza A/H1N1, and some of these can cause liver injury. Exposure to influenza strains that circulated 50–60 years ago might provide cross‐protection against the influenza A/H1N1 (2009) virus. Because the mean age of our study population is under 50 years, the possible role of the low preexisting immunity against pandemic 2009 influenza A/H1N1, which may affect the strength of the immunological response, cannot be excluded. Although duration of hospitalization was limited owing to hospital capacities during the influenza outbreak, there was still evident a relationship between the duration of hospitalization and the results of the liver enzyme tests. There are limited data of liver abnormalities during chronic conditions associated with both hypoxia and inflammation. Liver damage was connected to chronic obstructive pulmonary disease, which is strengthening our presumption of hypoxia and SIRS as the causative agents. , Whether liver enzymes provide clinical information additional to CRP requires further studies. The main limitation of this study is the retrospective nature of the collected data. In hospitalized patients, clinical attention is on the acute infection of the respiratory tract, so the clinical importance of liver involvement remained unclear. As previously mentioned, this is the first report comparing liver involvement in seasonal and pandemic influenza. These findings support the concept of the pandemic influenza A/H1N1 (2009) as an illness with significant immune response that in combination with moderate hypoxia caused by influenza respiratory illness may lead to hepatocellular injury and finally result in different clinical and laboratory features than in previous seasonal epidemics.

Acknowledgements

None.

Potential conflicts of interest

None.

Funding

N. Papic was supported by an ESCMID Training Fellowship program and Croatian Science Foundation Doctoral Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
  15 in total

1.  Kupffer cell-dependent hepatitis occurs during influenza infection.

Authors:  Noelle K Polakos; Judith C Cornejo; Debbie A Murray; Kate O Wright; John J Treanor; I Nicholas Crispe; David J Topham; Robert H Pierce
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

2.  Liver involvement in severe human influenza a H1N1.

Authors:  Raúl Carrillo-Esper; Estela Pérez-Bustos; Sofía Ornelas-Arroyo; Jorge Albores-Saavedra; Misael Uribe
Journal:  Ann Hepatol       Date:  2010 Jan-Mar       Impact factor: 2.400

3.  Association between elevated liver enzymes and C-reactive protein: possible hepatic contribution to systemic inflammation in the metabolic syndrome.

Authors:  Arthur Kerner; Ophir Avizohar; Ron Sella; Peter Bartha; Oren Zinder; Walter Markiewicz; Yishai Levy; Gerald J Brook; Doron Aronson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-10-21       Impact factor: 8.311

Review 4.  Cellular and cytokine-mediated mechanisms of inflammation and its modulation in immune-mediated liver injury.

Authors:  G Tiegs
Journal:  Z Gastroenterol       Date:  2007-01       Impact factor: 2.000

5.  Association between serum gamma-glutamyltransferase and C-reactive protein.

Authors:  Duk-Hee Lee; David R Jacobs
Journal:  Atherosclerosis       Date:  2005-02       Impact factor: 5.162

Review 6.  Liver in systemic disease.

Authors:  Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2008-07-14       Impact factor: 5.742

7.  Prevalence of COPD in primary care clinics: correlation with non-respiratory diseases.

Authors:  Yoshiaki Minakata; Hisatoshi Sugiura; Toshiyuki Yamagata; Satoru Yanagisawa; Tomohiro Ichikawa; Akira Koarai; Keiichirou Akamatsu; Tsunahiko Hirano; Kazuto Matsunaga; Masakazu Ichinose
Journal:  Intern Med       Date:  2008-01-15       Impact factor: 1.271

8.  Hypoxic hepatitis caused by acute exacerbation of chronic respiratory failure: a case-controlled, hemodynamic study of 17 consecutive cases.

Authors:  J Henrion; P Minette; L Colin; M Schapira; A Delannoy; F R Heller
Journal:  Hepatology       Date:  1999-02       Impact factor: 17.425

9.  Systemic viral infections and collateral damage in the liver.

Authors:  David H Adams; Stefan G Hubscher
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

10.  Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza.

Authors:  Jesus F Bermejo-Martin; Raul Ortiz de Lejarazu; Tomas Pumarola; Jordi Rello; Raquel Almansa; Paula Ramírez; Ignacio Martin-Loeches; David Varillas; Maria C Gallegos; Carlos Serón; Dariela Micheloud; Jose Manuel Gomez; Alberto Tenorio-Abreu; María J Ramos; M Lourdes Molina; Samantha Huidobro; Elia Sanchez; Mónica Gordón; Victoria Fernández; Alberto Del Castillo; Ma Angeles Marcos; Beatriz Villanueva; Carlos Javier López; Mario Rodríguez-Domínguez; Juan-Carlos Galan; Rafael Cantón; Aurora Lietor; Silvia Rojo; Jose M Eiros; Carmen Hinojosa; Isabel Gonzalez; Nuria Torner; David Banner; Alberto Leon; Pablo Cuesta; Thomas Rowe; David J Kelvin
Journal:  Crit Care       Date:  2009-12-11       Impact factor: 9.097

View more
  26 in total

Review 1.  Impact of COVID-19 in Liver Disease Progression.

Authors:  Miguel Angel Martinez; Sandra Franco
Journal:  Hepatol Commun       Date:  2021-05-31

2.  Combination activity of neuraminidase inhibitor oseltamivir and α-tocopherol in influenza virus A (H3N2) infection in mice.

Authors:  Angel S Galabov; Milka Mileva; Lora Simeonova; Galina Gegova
Journal:  Antivir Chem Chemother       Date:  2016-06-24

Review 3.  Diminished immune responses with aging predispose older adults to common and uncommon influenza complications.

Authors:  Spencer R Keilich; Jenna M Bartley; Laura Haynes
Journal:  Cell Immunol       Date:  2019-10-10       Impact factor: 4.868

4.  Distinctive clinical and laboratory features of COVID-19 and H1N1 influenza infections among hospitalized pediatric patients.

Authors:  Ali Alsuheel Asseri; Ayed A Shati; Saleh M Al-Qahtani; Ibrahim A Alzaydani; Ahmed A Al-Jarie; Mohammed J Alaliani; Abdelwahid Saeed Ali
Journal:  World J Pediatr       Date:  2021-05-10       Impact factor: 2.764

Review 5.  Adipocyte inflammation and pathogenesis of viral pneumonias: an overlooked contribution.

Authors:  Pablo C Alarcon; Michelle S M A Damen; Rajat Madan; George S Deepe; Paul Spearman; Sing Sing Way; Senad Divanovic
Journal:  Mucosal Immunol       Date:  2021-05-06       Impact factor: 7.313

6.  Liver Biochemistry During the Course of Influenza A/H1N1 Infection.

Authors:  Charalampos Seretis; Emmanuel Lagoudianakis; Nikolaos Salemis; Apostolos Pappas; George Gemenetzis; Fotios Seretis; Stavros Gourgiotis
Journal:  Gastroenterology Res       Date:  2013-07-14

Review 7.  The hidden burden of influenza: A review of the extra-pulmonary complications of influenza infection.

Authors:  Subhashini A Sellers; Robert S Hagan; Frederick G Hayden; William A Fischer
Journal:  Influenza Other Respir Viruses       Date:  2017-09       Impact factor: 4.380

8.  Prognosis of 18 H7N9 avian influenza patients in Shanghai.

Authors:  Shuihua Lu; Tao Li; Xiuhong Xi; Qingguo Chen; Xuhui Liu; Binxing Zhang; Jiaxian Ou; Jie Liu; Qin Wang; Biao Zhu; Xinian Liu; Chunxue Bai; Jieming Qu; Hongzhou Lu; Zhiyong Zhang; Yuanlin Song
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

9.  Alteration of liver function due to H1N1 infection: a case report.

Authors:  Ahmed H Alhammadi; Mohamed A Hendaus; Anas A Kayoum
Journal:  Clin Exp Gastroenterol       Date:  2013-09-16

10.  Cytochrome P450-mediated drug interactions in COVID-19 patients: Current findings and possible mechanisms.

Authors:  Mahmoud A El-Ghiaty; Sherif M Shoieb; Ayman O S El-Kadi
Journal:  Med Hypotheses       Date:  2020-06-26       Impact factor: 1.538

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.